Veno-occlusive disease-like hepatotoxicity in two children receiving chemotherapy for Wilms' tumor and clear cell sarcoma of kidney.
- 1 January 1998
- journal article
- case report
- Published by Taylor & Francis in Pediatric Hematology and Oncology
- Vol. 15 (1) , 85-89
- https://doi.org/10.3109/08880019809009513
Abstract
We report two pediatric cases who developed veno-occlusive disease-like hepatotoxicity while receiving chemotherapy for Wilms' tumor and clear cell sarcoma of kidney. The chemotherapeutics, including vincristine, actinomycin D, and epirubicin in case 1 and vincristine and actinomycin D in case 2, were given before the hepatotoxicity developed. Other possible causes of hepatotoxicity were excluded. Recovery was observed with supportive therapy after 2 and 1 weeks, respectively. After recovery, the children tolerated continued chemotherapy without any decrease in the doses of drugs. We conclude that vincristine and actinomycin D were the cause of this rare from of hepatotoxicity and that chemotherapy for the underlying malignant disease could be given safely after clinical recovery.Keywords
This publication has 6 references indexed in Scilit:
- Severe hepatic toxicity after treatment with vincristine and dactinomycin using single-dose or divided-dose schedules: a report from the National Wilms' Tumor Study.Journal of Clinical Oncology, 1990
- Hepatotoxicity and actinomycin DThe Lancet, 1990
- Hepatic veno-occlusive diseaseThe American Journal of Medicine, 1986
- Veno-Occlusive Disease and Peliosis of the Liver Complicating the Course of Wilms' TumourActa Radiologica. Diagnosis, 1985
- Hepatotoxicity following vincristine therapyCancer, 1984
- Veno-occlusive disease of the liver in children following chemotherapy for acute myelocytic leukemiaCancer, 1983